Progress Adult Study

Completed

• Conditions: HIV; Depression
• Interventions: Drug: standard regimens according to the Thai Ministry of Public Health national guidelines

• Registration Number: NCT01328275
• Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Brief Summary

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

Detailed Description

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2011-03-02
• Study First Submitted QC: 2011-04-01
• Study First Posted: 2011-04-04
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-09
• Last Update Posted: 2016-05-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5600

Inclusion Criteria

1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens
2. Signed consent form
3. Age> 18 years

Exclusion Criteria

1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.
2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.
3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.
4. Patients who have been diagnosed by a medical condition that Alcoholism

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	standard regimens according to the Thai Ministry of Public Health national guidelines	long-term follow-up of HIV-infected patients on ART

Primary Outcome Measures

Name	Time	Method
HIV related adverse events	1 year	Time until patient has HIV related adverse events

Secondary Outcome Measures

Name	Time	Method
Immunological failure	1 year	time to immunological failure
virological failure	1 year	time to virological failure
the change of quality of life	1 year	time to change of quality of life
depression	1 year	time when patient develops depression
genotypic resistance	1 year	time to developing genotypic resistance

Trial Locations

Locations (3)

HIV-NAT, Thai Red Cross AIDS Research Centre; 🇹🇭 Bangkok, Thailand

Sanpatong Hospital; 🇹🇭 Chiang Mai, Thailand

Bamrasnaradura infectious disease institute; 🇹🇭 Nonthaburi, Thailand